SEC Form 4 · accession 0001250853-19-000036
Kindred Biosciences, Inc. · KIN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jan 22, 2019
Accepted (ET)
Jan 24, 2019 · 9:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 22, 2019 | M | 37,500 | — | A | 1,943,571 | D | |
| Common StockF2 | Jan 22, 2019 | F | 12,968 | $10.12 | D | 1,930,603 | D | |
| Common StockF2 | Jan 23, 2019 | F | 8,646 | $9.945 | D | 1,921,957 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jan 22, 2019 | M | 37,500 | D | — | — | Common Stock | 37,500 | 112,500 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2These shares are being surrendered to satisfy a tax withholding obligation of the reporting person.
- F3On January 22, 2018, the reporting person was granted 150,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.